"What may be happening, and we don't know for sure, is that when you stop them, your body's left in a GLP-1 deficit which has a major impact on the satiety signal going to the brain," says Whyte
Large-scale clinical trials with semaglutide (STEP 1) found that roughly 40% of total weight loss came from lean body mass (LBM), which is higher than the roughly 25% expected during typical physiological weight loss (the so-called "quarter fat-free mass rule")
Adems, GHK-Cu tiene propiedades antiinflamatorias y antioxidantes, que contribuyen a sus efectos regenerativos de los tejidos
However, tentative approval does not permit marketing
It functions as a GIP agonist, not antagonist or blocker.
Journal of Cosmetic Dermatology.